LUCY logo

Innovative Eyewear (LUCY)

Profile

Full Name

Innovative Eyewear, Inc.

Ticker Symbol

LUCY

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

August 15, 2022

Indexes

Not included

Website

http://www.lucyd.co

Employees

11

Key Details

Price

$2.35(-52.53%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.64M(+41.99% YoY)

Annual EPS

-$5.19(+52.25% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.35
LUCY price is $2.35

30-Day Relative Volume

3.32
LUCY 30-day relative volume is 3.32

Price Performance

Price Most recent change

-52.53%
LUCY price was down -52.53% on Apr 11, 2025

Price YTD change

-52.24%
LUCY price is down -52.24% since January 1st

Price 1-year change

-55.15%
LUCY price is down -55.15% year-on-year

Price 3-year change

-
LUCY price 3-year change is unknown

Price Range

Price All-time high

$117.80
LUCY price is currently -98.01% below its historical high of $117.80

Price 3-year low

$0.17
LUCY price is currently +1298.81% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$5.76M
LUCY market capitalization is $5.76 million

Market cap 3-year change

-
LUCY market capitalization 3-year change is unknown

Market cap All-time high

$43.04M
LUCY market capitalization is currently -86.61% below its historical high of $43.04 million

Market cap sector rank

14.63%
LUCY market capitalization is higher than 14.63% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+270.65%
LUCY shares outstanding is up +270.65% year-on-year

Shares Outstanding 3-Year Change

+535.55%
LUCY shares outstanding is up +535.55% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.19
LUCY beta is 1.19

200-day SMA

$5.71
LUCY price is currently -58.86% below its 200-day simple moving average

50-day SMA

$3.83
LUCY price is currently -38.61% below its 50-day simple moving average

RSI

44.04
LUCY 14-day relative strength index is 44.04

Volume

3.32
LUCY 30-day relative volume is 3.32

ATR

$0.68
LUCY average true range is $0.68

10-day Historical Volatility

641.48%
LUCY 10-day historical volatility is 641.48%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.64M
LUCY annual revenue is $1.64 million

Revenue Analysts estimate

$10.30M
LUCY annual revenue is currently -84.11% lower than the consensus analysts' forecast

Revenue 1-year change

+41.99%
LUCY annual revenue is up +41.99% year-on-year

Revenue Sector rank

14.33%
LUCY annual revenue is higher than 14.33% of companies in Healthcare sector

EPS

EPS

-$5.19
LUCY annual earnings per share is -$5.19

EPS Analysts estimate

-$2.40
LUCY annual earnings per share is currently +116.25% higher than the consensus analysts' forecast

EPS 1-year change

+52.25%
LUCY annual earnings per share is up +52.25% year-on-year

EPS Sector rank

18.74%
LUCY annual earnings per share is higher than 18.74% of companies in Healthcare sector

Profit

Gross profit

$215.20K
LUCY annual gross profit is $215.20 thousand

Gross margin

13.15%
LUCY annual gross profit margin is 13.15%

Operating profit

-$7.92M
LUCY annual operating income is -$7.92 million

Operating margin

-484.20%
LUCY annual operating profit margin is -484.20%

Net income

-$7.77M
LUCY annual net profit is -$7.77 million

Net margin

-474.60%
LUCY annual net profit margin is -474.60%

Expenses

Total expenses

$9.56M
LUCY annual total expenses is $9.56 million

Operating expenses

$8.14M
LUCY annual total operating expenses is $8.14 million

Cost of goods sold

$1.42M
LUCY annual cost of goods sold is $1.42 million

Selling, general & administrative expenses

$7.18M
LUCY annual SGA is $7.18 million

Depreciation and amortization

$149.40K
LUCY annual depreciation & amortization is $149.40 thousand

Interest expense

$0.00
LUCY annual interest expense is $0.00

Income tax

-
LUCY annual income tax value is unknown

EBIT & EBITDA

EBIT

-$7.77M
LUCY annual earnings before interest & taxes is -$7.77 million

EBITDA

-$7.62M
LUCY annual EBITDA is -$7.62 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$9.84M
LUCY annual total assets is $9.84 million

Non current assets

$600.10K
LUCY annual long term assets is $600.10 thousand

Current assets

$9.24M
LUCY annual total current assets is $9.24 million

Cash and cash equivalents

$2.63M
LUCY annual cash & cash equivalents is $2.63 million

Accounts receivable

$107.90K
LUCY annual accounts receivable is $107.90 thousand

Inventory

$831.80K
LUCY annual inventory is $831.80 thousand

Liabilities

Total liabilities

$743.20K
LUCY annual total liabilities is $743.20 thousand

Long term liabilities

$5400.00
LUCY annual total long term liabilities is $5400.00

Current liabilities

$737.70K
LUCY annual total current liabilities is $737.70 thousand

Accounts payable

$692.80K
LUCY annual accounts payable is $692.80 thousand

Debt

Total debt

$0.00
LUCY annual total debt is $0.00

Total debt 1-year change

0%
LUCY {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
LUCY annual long term debt value is unknown

Short term debt

-
LUCY annual short term debt value is unknown

Equity & Capital

Shareholders equity

$9.10M
LUCY annual stockholders equity is $9.10 million

Book value

$9.10M
LUCY annual book value is $9.10 million

Retained earnings

-$24.74M
LUCY annual retained earnings is -$24.74 million

Working capital

$8.50M
LUCY annual working capital is $8.50 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$6.74M
LUCY annual cash flow from operations is -$6.74 million

Cash from operations 1-year change

-16.88%
LUCY annual cash flow from operations is down -16.88% year-on-year

Cash from investing

-$5.16M
LUCY annual cash flow from investing activities is -$5.16 million

Cash from investing 1-year change

-2496.68%
LUCY annual cash flow from investing activities is down -2496.68% year-on-year

Cash from financing

$10.24M
LUCY annual cash flow from financing activities is $10.24 million

Cash from financing 1-year change

+53.77%
LUCY annual cash flow from financing activities is up +53.77% year-on-year

CAPEX

CAPEX

$267.00K
LUCY annual capital expenditures is $267.00 thousand

CAPEX 1-year change

+6.16%
LUCY annual capital expenditures is up +6.16% year-on-year

Free Cash Flow

Free cash flow

-$7.01M
LUCY annual free cash flow is -$7.01 million

Free cash flow 1-year change

-16.43%
LUCY annual free cash flow is down -16.43% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

13.15%
LUCY annual gross profit margin is 13.15%

Operating margin

-484.20%
LUCY annual operating profit margin is -484.20%

Net margin

-474.60%
LUCY annual net profit margin is -474.60%

ROA & ROE

ROA

-96.74%
LUCY annual return on assets is -96.74%

ROE

-106.00%
LUCY annual return on equity is -106.00%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
LUCY price to earnings ratio value is unknown

PE ratio Sector rank

-
LUCY price to earnings ratio is unknown

PB Ratio

PB ratio

0.63
LUCY price to book ratio is 0.63

PB ratio Sector rank

34.95%
LUCY price to book ratio is higher than 34.95% of companies in Healthcare sector

PS Ratio

PS ratio

3.52
LUCY price to sales ratio is 3.52

PS ratio Sector rank

57.95%
LUCY price to sales ratio is higher than 57.95% of companies in Healthcare sector

Enterprise value

Enterprise value

$3.13M
LUCY enterprise value is $3.13 million

Enterprise value Sector rank

17.26%
LUCY enterprise value is higher than 17.26% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.41
LUCY EV/EBITDA is -0.41

EV/EBITDA Sector rank

53.26%
LUCY EV/EBITDA is higher than 53.26% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

12.52
LUCY annual current ratio is 12.52

Quick ratio

11.40
LUCY annual quick ratio is 11.40

Leverage

Debt to equity

0.00
LUCY annual debt to equity ratio is 0.00

Interest coverage ratio

-
LUCY annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
LUCY piotroski f-score value is unknown

Altman Z-Score

-0.27
LUCY altman z-score is -0.27

Analyst ratings

Recent major analysts updates

Mar 26, 24 Maxim Group
Buy
Sep 11, 23 Maxim Group
Buy

Institutional Ownership

Similar stocks

CNTG logo
Centogene NV (CNTG)
Dogwood Therapeutics (DWTX)
CELZ logo
Creative Medical Technology Holdings (CELZ)
TNON logo
Tenon Medical (TNON)
IBO logo
Impact BioMedical (IBO)
WORK Medical Technology Group LTD (WOK)
MOVE logo
Movano (MOVE)
LIPO logo
Lipella Pharmaceuticals (LIPO)
MSPR logo
MSP Recovery (MSPR)
  • What is the ticker symbol for Innovative Eyewear?
  • Does Innovative Eyewear pay dividends?
  • What sector is Innovative Eyewear in?
  • What industry is Innovative Eyewear in?
  • What country is Innovative Eyewear based in?
  • When did Innovative Eyewear go public?
  • Is Innovative Eyewear in the S&P 500?
  • Is Innovative Eyewear in the NASDAQ 100?
  • Is Innovative Eyewear in the Dow Jones?
  • When does Innovative Eyewear report earnings?
  • Should I buy Innovative Eyewear stock now?

What is the ticker symbol for Innovative Eyewear?

The ticker symbol for Innovative Eyewear is NASDAQ:LUCY

Does Innovative Eyewear pay dividends?

No, Innovative Eyewear does not pay dividends

What sector is Innovative Eyewear in?

Innovative Eyewear is in the Healthcare sector

What industry is Innovative Eyewear in?

Innovative Eyewear is in the Medical Instruments & Supplies industry

What country is Innovative Eyewear based in?

Innovative Eyewear is headquartered in United States

When did Innovative Eyewear go public?

Innovative Eyewear's initial public offering (IPO) was on August 15, 2022

Is Innovative Eyewear in the S&P 500?

No, Innovative Eyewear is not included in the S&P 500 index

Is Innovative Eyewear in the NASDAQ 100?

No, Innovative Eyewear is not included in the NASDAQ 100 index

Is Innovative Eyewear in the Dow Jones?

No, Innovative Eyewear is not included in the Dow Jones index

When does Innovative Eyewear report earnings?

The date for Innovative Eyewear's next earnings report has not been announced yet

Should I buy Innovative Eyewear stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page